The PREPARE study: benefits of pharmacogenetic testing are unclear - Authors' reply.

Autor: Swen JJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, 2300 RC Leiden, Netherlands., Manson LEN; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, 2300 RC Leiden, Netherlands., Böhringer S; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, 2300 RC Leiden, Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Center, 2300 RC Leiden, Netherlands., Pirmohamed M; Department of Pharmacology and Therapeutics, Wolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, UK., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, 2300 RC Leiden, Netherlands. Electronic address: h.j.guchelaar@lumc.nl.
Jazyk: angličtina
Zdroj: Lancet (London, England) [Lancet] 2023 Jun 03; Vol. 401 (10391), pp. 1851-1852.
DOI: 10.1016/S0140-6736(23)00852-8
Databáze: MEDLINE